版本:
中国

BRIEF-Cadila Healthcare's Zydus gets final FDA nod for drug to treat allergy symptoms

May 23 Cadila Healthcare Ltd:

* Says Zydus receives final approval from U.S. FDA for cyproheptadine hydrochloride tablets usp

* Drug intended to relieve allergy symptoms; to be produced at group's formulations manufacturing facility at Pharma SEZ in Ahmedabad Source text: bit.ly/2rOe3Lc Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐